Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.

Hartwell, D; Jones, J; Baxter, L; Shepherd, J; (2011) Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 15 (17). i-xii, 1-210. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta15170

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.3310/hta15170

Abstract

Share

Download

Filename: FullReport-hta15170.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar